Medical Technology & Devices Analysts, along with a TAVR (Transcatheter Aortic Valve Replacement) implanter, who recently switched to Medtronic, discuss whether Medtronic can take the TAVR share from Edwards Lifesciences on an Analyst/Industry conference call to be held on February 7 at 11 am. Webcast Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on EW:
- Edwards Lifesciences downgraded to Market Perform from Outperform at Raymond James
- Edwards Lifesciences downgraded to Market Perform at Raymond James
- Early notable gainers among liquid option names on February 1st
- Edwards Lifesciences price target raised to $76 from $68 at Canaccord
- EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS